Exploring Global Cooperation Strategies for Advanced Regenerative Medicine to Treat Rare and Intractable Diseases

Ministry of Health and Welfare and Regenerative Medicine Advanced Foundation
to Hold the '2025 Annual Symposium'

The Ministry of Health and Welfare and the Regenerative Medicine Advanced Foundation will hold the '2025 RMAF Annual Symposium' under the theme 'Toward Innovation and Access: New Trends in Advanced Regenerative Medicine' at the Peace & Park Convention Hall in the War Memorial of Korea, Yongsan-gu, Seoul, on October 28.

This international symposium, held to share the latest trends in systems and technologies in the field of advanced regenerative medicine and to discuss its future direction, is expected to bring together around 200 participants, including domestic and international experts in advanced regenerative medicine, industry representatives, and related organizations.

During the symposium, both domestic and international experts will present on global policy and regulatory trends, as well as technological and investment developments in the field of advanced regenerative medicine. The policy and regulatory session will cover the latest policies and regulatory trends in leading countries such as Japan, Taiwan, Germany, and Canada, and discuss their implications. The technology and investment session will introduce the current status of cutting-edge technology development, such as gene-editing therapies for rare diseases and next-generation CAR-T therapies, as well as investment trends.

There will also be a ceremony to recognize and commend individuals who have contributed to the advancement and promotion of advanced regenerative medicine, including the presentation of the Minister of Health and Welfare Award. Professor Lee Raeseok of Seoul St. Mary's Hospital, Catholic University of Korea, was highly praised for his contribution to technological advancement by conducting clinical research to evaluate the safety and efficacy of specific T-cell therapy for COVID-19 patients, thereby demonstrating the potential of advanced regenerative medicine in treating intractable infectious diseases. Kim Hyunil, CEO of Optifarm, was recognized for his contribution to the promotion of advanced regenerative medicine technology and industry by developing genetically modified pigs for organ transplantation using gene-editing technology.

Shin Kkotshigae, Director of Advanced Medical Support at the Ministry of Health and Welfare, stated, "In February this year, we introduced a treatment system to provide new therapeutic opportunities to patients with serious, rare, and intractable diseases," and added, "The government will activate clinical research, which forms the foundation of treatment, and rationally improve the review process to ensure that regenerative therapies based on safety and efficacy are promptly established in the field."

Park Sora, President of the Regenerative Medicine Advanced Foundation, said, "I hope this symposium will serve as an opportunity to build consensus on the development of advanced regenerative medicine systems and technologies, and to explore ways for global cooperation."

This content was produced with the assistance of AI translation services.